跳至主要内容
临床试验/ISRCTN13841211
ISRCTN13841211已完成未知

The addition of ACT or a Talking Control to treatment as usual for the management of dysfunction in advanced cancer: a feasibility randomised controlled trial

Camden and Islington NHS Foundation Trust (UK)0 个研究点目标入组 42 人开始时间: 2015年7月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/26865162 protocol 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35596193/ Qualitative analysis of sessions (added 18/08/2023) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/30511788/ (added 18/08/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. A clinical diagnosis of advanced cancer defined as disease not amenable to curative treatment, those with metastases at diagnosis, those at first or subsequent extensive recurrence and those receiving palliative treatments
  • 2.Total FACTG score of < 81
  • 3. Agreement to be randomised
  • 4. Sufficient understanding of English to engage in ACT

排除标准

  • 1 Clinician estimated survival of less than 4 months
  • 2. Age under 18 years

研究者

发起方
Camden and Islington NHS Foundation Trust (UK)

相似试验